2Seventy Bio Inc (TSVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 22,938 | 2,926 | 13,534 | 8,967 | 12,435 |
| Cost of Goods | 5,153 | 5,520 | 5,768 | 3,453 | 3,269 |
| Gross Profit | 17,785 | -2,594 | 7,766 | 5,514 | 9,166 |
| Operating Expenses | 20,458 | 21,192 | 22,475 | 33,036 | 60,589 |
| Operating Income | -2,520 | -23,266 | -13,941 | -27,069 | -51,154 |
| Other Income | 3,002 | 3,746 | 4,008 | 51,948 | -1,519 |
| Pre-tax Income | 482 | -19,520 | -9,933 | 24,879 | -52,673 |
| Net Income Continuous | 482 | -19,520 | -9,933 | 24,879 | -52,673 |
| Net Income | $482 | $-19,520 | $-9,933 | $24,879 | $-52,673 |
| EPS Basic Total Ops | 0.01 | -0.38 | -0.19 | 0.48 | -1.01 |
| EPS Basic Continuous Ops | 0.01 | -0.37 | -0.19 | 0.48 | -1.01 |
| EPS Diluted Total Ops | 0.01 | -0.35 | -0.19 | 0.45 | -1.01 |
| EPS Diluted Continuous Ops | 0.01 | -0.35 | -0.19 | 0.45 | -1.01 |
| EPS Diluted Before Non-Recurring Items | 0.01 | -0.31 | -0.18 | -0.29 | -0.81 |
| EBITDA(a) | $-882 | $-21,611 | $-12,283 | $-25,393 | $-49,047 |